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Formula of Trophenium.
Ganglion Blocking Actions.
Using the cat nictitating membrane preparation, Trophenium was found to be ten times as potent as hexamethonium iodide (C6) as a ganglion blocking agent. Its duration of action measured at the ED50 was half that of hexamethonium. Trophenium was found to be one and a half times as potent as trimetaphan ( + ) camphorsulphonate (Arfonad, Roche), with a similar duration of action at the ED50.
•Registered trade mark, Duncan, Flockhart & Co. Ltd.
Actions on the Circulation.
The intravenous injection into the anaesthetized cat of a small dose (0.1 mg/kg) of Trophenium caused a short-duration fall in blood pressure of about 70 mm Hg. When the blood pressure had reached its lowest level an injection of a large dose of hexamethonium produced no further fall. Similarly, the injection of a large dose of Trophenium during the maximal hypotension produced by hexamethonium caused no further fall in blood pressure. Trophenium abolished the pressor response to injections of small doses of nicotine. It is likely, therefore, that the hypotensive action of Trophenium is due to blockade of the sympathetic ganglia. In the cat, Trophenium, by intravenous injection, was found to be twenty times as potent as hexamethonium as a hypotensive agent. Its duration of action was half that of hexamethonium at the ED50. Figure 2 illustrates a typical experiment in which the depressor actions of Trophenium and trimetaphan were compared in a cat anaesthetized by chloralose-urethane. The drugs were injected in random order. The upper graph shows the duration of action of the drugs as measured by the time taken from the injection until the blood pressure had returned half way back to the preinjection level. The duration of action of trimetaphan was much greater than that of Trophenium as the dose exceeded 0.1 mg/kg.
The lower graph shows that the maximal fall in blood pressure produced by trimetaphan was greater than that produced by Trophenium or by a large dose of hexamethonium. This can be taken as additional evidence that the depressor actions 342 of trimetaphan are not entirely due to its ganglion blocking action (McCubbin and Page, 1952) . Using cats anaesthetized by pentobarbitone sodium, controlled hypotension was produced by injections, repeated every 30 seconds, of 0.02 mg/kg of Trophenium. It was found that controlled hypotension could be produced more conveniently by means of an intravenous infusion of the drug using dosage rates of from 0.2 to 0.1 mg/kg/min. Figure 3 illustrates a typical blood pressure tracing made during an infusion of Trophenium. It shows that a few minutes after the blood pressure had fallen following the start of the infusion, there was a slight compensatory rise in pressure to a steady level. Recovery was rapid after stopping the infusion. This compensatory rise in pressure was often, though not invariably, seen and it was also found to occur with comparable infusions of trimetaphan. Single injections of Trophenium and of hexamethonium iodide failed to lower the blood pressure again during the compensatory rise and it is likely that this response represents a spontaneous partial return of the tone of the blood vessels and is similar to that seen in sympathectomized patients. Zaimis (1955) showed that this could be explained by the peripheral vessels becoming more sensitive to the actions of adrenaline and noradrenaline during ganglion blockade. Table I shows the effect of varying the infusion rate of Trophenium on the recovery time as measured by the interval from the end of the infusion until the blood pressure had returned half way back to the pre-infusion level (50 per cent recovery time).
Very prolonged recovery times have not been seen following infusions of Trophenium. However, they have occasionally been seen with infusions of trimetaphan in the anaesthetized cat. In one experiment the 50 per cent recovery time following an infusion of 2 mg/kg trimetaphan at a dosage rate of 0.1 mg/kg/min was 185 minutes. The blood pressure did not return to its original level until 375 minutes after the end of the infusion.
The pressor drugs, adrenaline and methylamphetamine, are very effective antagonists to the hypotension produced by Trophenium (figs. 4 and 5). Since Trophenium blocks the reflex vasodilator responses to pressor drugs, their effects are potentiated during Trophenium blockade. Therefore care would have to be taken to use smaller doses than usual of these drugs if they are required during infusions of Trophenium.
Trophenium was not observed to produce any adverse cardiac effects in anaesthetized cats or in conscious or anaesthetized rabbits. Heart block was not seen and even with lethal doses no changes, apart from bradycardia, occurred until anoxia was marked.
Actions on the Respiration.
When administered to anaesthetized cats at dosage rates of up to 3.2 mg/kg/min, Trophenium produced a slight stimulation of respiration. Table II illustrates the results which were obtained. The respiratory rates and minute volumes are presented as percentages of the pre-infusion values.
Acute Toxicity. Table III shows the toxicity of Trophenium to mice by various routes.
After administration of Trophenium by the subcutaneous and intraperitoneal routes, the first symptom to be seen was that of sedation which was followed by paralysis and then respiratory Trophenium dosage rate 0.1 mg/kg/min. At A, adrenaline hydrochloride 3 /<g.
TROPHENIUM INFUSION I MIN.
Fio. 5 Antagonism to Trophenium hypotension in the cat anaesthetized by chloralose-urethane. Trophenium dosage rate 0.1 mg/kg/min. At M, methylamphetamine 0.1 mg. failure. Examination of the dead animals showed no tissue damage at the injection sites, and all the organs appeared to be normal. Paralysis occurred immediately after intravenous injections, but in the animals which survived recovery was rapid, being complete within one minute after the injection.
Pilot studies showed that Trophenium had similar toxicities in rats, rabbits and cats.
Subacute Toxicity Studies.
Newly weaned Hooded Wistar rats received daily subcutaneous injections of 50 mg/kg of Trophenium (5 per cent w/v in 0.9 per cent saline). No significant difference was observed between the growth rates of the control group, the group injected with saline, and the group injected with Trophenium over the period from weaning until maturity. The Trophenium injections caused local tissue damage with dry scab formation. This cleared within 2-3 days of changing the injection site. Trophe- nium. Although Trophenium caused tissue damage by subcutaneous injection in rats, it was not found to do so in the mouse, rabbit, cat, monkey and man.
The Production of Tissue Damage by
The Side Effects of Trophenium.
The atropine-like side actions of the drug are negligible. The subcutaneous injection of a 5 mg dose in man did not produce tachycardia, dryness of the mouth or skin and vision was not affected. Animal experiments indicate that atropine is more than one thousand times as active as Trophenium in those respects; for example, the topical application of a 50 mg/ml solution of Trophenium to the eyes of mice failed to produce mydriasis, whereas the pupils were fully dilated by a similar application of atropine sulphate solution containing 10 ixg/ml. Similar results for the relative potency of the two drugs were obtained using them as antagonists to the action of acetylcholine on the isolated guineapig ileum.
Trophenium was not found to be a potent histamine liberator. The histamine-liberating properties of Trophenium and trimetaphan were examined by comparing the weal responses to intradermal injections of the drugs in the human forearm. Figure 6 illustrates some results obtained and shows that Trophenium is very much less active than trimetaphan as a histamine liberator. Using the chloralose anaesthetized cat in which the ganglia had been blocked by a large dose of hexamethonium, an intravenous injection of 1 mg/kg of Trophenium caused no further fall in the blood pressure whereas 30 seconds after the intravenous injection of 0.1 mg/kg of trimetaphan there was a fall in blood pressure of 31 mm Hg indicating a release of histamine by the drug (Macintosh and Paton, 1949) .
Conclusions
The animal experiments indicate that Trophenium is a safe and reliable drug which can be used to produce controlled hypotension in anaesthesia.
Its hypotensive action appears to be solely due to blockade of the sympathetic ganglia. The blood pressure rapidly returns to normal following the end of an infusion and no very prolonged recovery times have been seen, although they have sometimes occurred following comparable experiments with trimetaphan. The hypotensive effect of Trophenium is readily reversed by adrenaline and methylamphetamine.
Even in lethal doses, Trophenium had no adverse effects on the heart. Trophenium was found to be much less active than trimetaphan as a histamine liberator. It has negligible atropine-like side actions.
It is suggested that Trophenium could be administered as an intravenous saline drip in order to produce controlled hypotension during anaesthesia. Suitable concentrations of the drug would be from 0.5 mg/ml to 2 mg/ml and in these concentrations Trophenium is compatible with thiopentone.
THE USE OF PHENACYL HOMATROPINIUM CHLORIDE (TROPHENIUM) TO PRODUCE CONTROLLED HYPOTENSION DURING SURGICAL OPERATIONS
In 1953 Nicholson, Sarnoff and Crehan described the use of the new ganglion blocking agent trimetaphan camphorsulphonate (Arfonad) for the production of rapidly reversible hypotension during 25 surgical operations following its use by Sarnoff, Goodale and Sarnoff (1952) to produce graded reduction of arterial blood pressure in man in the treatment of acute pulmonary oedema. The first report in Britain of the use of trimetaphan to produce controlled hypotension during anaesthesia and surgery was by Magill, Scurr and Wyman (1953) who described their findings in five patients. Since that time many reports concerning its use in this country, on the Continent and in America have appeared in the literature.
We have had considerable experience with trimetaphan during the past 31 years and have for the most part found it a reliable hypotensive agent. The following disadvantages have been reported:
(1) Although trimetaphan acts as a ganglion blocking agent (Randall, Peterson and Lehmann, 1949) it is also said to owe part of its action as a hypotensive agent to a direct effect on the vessels (McCubbin and Page, 1952) and to the release of histamine (Mitchell, Newman, MacGillivray and Clark, 1951; Payne, 1956) . Theoretically, at least, it would seem that a drug causing such a complex effect would be less reliable than one which acted only at one point.
(2) Scurr and Wyman (1954) have described the development of tachyphylaxis in two cases following the administration of trimetaphan so that some patients become resistant to its hypotensive action.
(3) Occasionally the degree of hypotension has been marked and has remained so for a considerable period after the administration has been discontinued. In the presence of profound systemic arterial hypotension the glomerular filtration rate is reduced and, as trimetaphan is excreted partly by the kidneys (Gertner, Little and Bonnycastle, 1955) , might lead to a continuance of hypotension. This would be particularly liable to occur in patients with renal disease (Little, 1956) .
(4) Tachycardia due to autonomic imbalance may sometimes develop (Little, 1956) .
For these reasons we felt that a drug having a duration of action comparable to that of trimetaphan, but which had a pure ganglion blocking action and gave no evidence of histamine release, was worthy of clinical trial. Such a drug is phenacyl homatropinium chloride (Trophenium -Duncan, Flockhart & Co. Ltd.).
Selection of Patients.
The criteria used in selecting the patients for this trial were based primarily on the indication for controlled hypotension in surgery which one of us has stated to be " that situation in which the advantages will be of certain benefit to the patient and likely to outweigh the assumed risks." More specifically, the general state of the patient, type of operation and the skill and experience of the anaesthetist and operator must be assessed in each individual case before the use of controlled hypotension can be decided upon or justified. The chief contra-indications are advanced degenerative cardiovascular disease, renal and hepatic disease and low blood volume.
Operations.
The operative procedures in which hypotension was induced with Trophenium may be divided into two groups-general and thoracic (table IV) . There were 29 males and 10 females in the general surgical group and 21 males and 15 females in the thoracic group. In the latter, one patient was subjected to two separate operations, hypotension with Trophenium being used on both occasions. Age.
In the general surgical group the average age was 50 years (S.D. 17.6), a considerably higher figure than in the thoracic group where the average was 38 years (S.D. 12.5) (table V). Pre-operative State.
The two groups were hardly comparable because, although the patients undergoing thoracic operations were younger than those in the general surgical group, their general condition was poor, all of them having extensive pulmonary tuberculosis which in 22 of the 36 cases was bilateral. On the other hand, apart from two cases in this group with diabetes mellitus, which was well controlled under effective medical supervision, there was little else in the way of concurrent disease. In contrast, several of the older patients in the general surgical group were suffering from chronic disease of the respiratory or circulatory system or both, four were extremely overweight and two had pernicious anaemia (table VI) . mg to 52.5 mg, the average being 34.2 mg. In one case 160 mg gallamine triethiodide was used instead of d-tubocurarine chloride. Ventilation was achieved by manual compression of the bag of the Waters to-and-fro absorber unit.
General surgical cases. On 37 of the 39 occasions anaesthesia was induced by intravenous thiopentone sodium. The dosage varied from 200 mg to 700 mg, the average being 490 mg. A light plane of surgical anaesthesia was then maintained with a nitrous oxide-oxygen-trichloroethylene mix- 
Anaesthetic.
All patients were, of course, under a general anaesthestic. This varied considerably between the two series but within each series a standard technique was employed. Where necessary to obtain adequate muscular relaxation or to allow the respiration to be controlled the general anaesthetic was supplemented by a muscle relaxant agent. The methods employed can be summarized as follows:
Thoracic surgical cases. Induction of anaesthesia with thiopentone sodium 150-500 mg (average 480 mg) and maintenance with cyclopropane and oxygen. In one case nitrous oxide and oxygen were used for induction. As the patients were on controlled respiration during the period when the pleural cavity was open they all received d-tubocurarine chloride, the dose varying from 20 ture from a Boyle's apparatus, except in four cases in which Fluothane-oxygen was used. In two of these Fluothane-oxygen was also given to induce anaesthesia. Thirty of the cases received at least one intravenous injection of gallamine triethiode, the total amount of this relaxant varying from 60 mg to 160 mg with a mean of 100 mg. In seven cases d-tubocurarine chloride was employed, the dosage varying from 15 mg to 40 mg with a mean of 25 mg. In two of the patients receiving Fluothane and oxygen no relaxant was given. In four patients undergoing abdominal operations a mechanical positive pressure respirator (" Pneumomatic") was employed to ensure adequate pulmonary ventilation. During extra-abdominal operations the patients were allowed to breathe spontaneously.
Hypotensive technique.
The blood pressure was recorded by a mercury sphygmomanometer before and after induction of anaesthesia. In all cases in the two series, once a steady level of light surgical anaesthesia had been reached, an intravenous infusion containing Trophcnium was set up by direct puncture of the cephalic vein on the radial side of the wrist, the standard blood-giving set being employed. The patient was then put into position for the operation. Various concentrations of Trophenium in normal saline solution were employed (table VII) . The most satisfactory concentration was found to be 2 mg/ml. The arterial blood pressure was again checked and the intravenous administration begun. Initially the rate was set at about 100-120 drops per minute and while this was being counted by a nurse the blood pressure level was repeatedly checked by the anaesthetist. Once the pressure was falling steadily and had reached a systolic level about 10 mm Hg higher than the final level desired, the drip rate was slowed to approximately 40-60 drops per minute. The level of systolic blood pressure aimed at varied on each occasion and was decided from the nature of the operation, the general condition of the patient-in particular, his resting blood pressure level-and later, once the operation had started, by the amount of bleeding which was actually occurring. Preparation of the patient for operation was now started. A careful check was kept on blood pressure at this time and appropriate adjustment of the drip rate made if the fall became excessive or the pressure began to rise. Preparation of skin and towelling having been completed, a final blood pressure check was made and if this was satisfactory the operation was started. As had been found previously with trimetaphan, it was advisable to make sure that a satisfactory level of hypotension had been achieved before the operation was begun. Once the operation was well under way the stability or otherwise of the blood pressure level and the amount of bleeding in the wound determined the drip rate. The level of blood pressure was checked at frequent intervals throughout the operation. In addition, other observations made included the pulse rate, rhythm and volume, the state of the pupils, the colour and dryness of the patient's skin, the capillary refill time, the respiratory rate and tidal exchange, and the level of anaesthesia. Where possible drifts in the blood pressure level were anticipated, suitable adjustment of drip rate was made to counteract them before they became excessive. In general, however, the ideal was to attain a satisfactory blood pressure level rapidly and thereafter to make as few adjustments to the drip as possible. Excessive or sudden falls in blood pressure below the range desirable for the individual case usually recovered rapidly when the drip was stopped. It was important, however, to keep a close and constant watch on the pressure at such times, both to avoid excessive prolongation of extreme hypotension and to observe when recovery of blood pressure was beginning, because once it had started to rise it frequently did so very sharply, and if the administration of a hypotensive agent was not quickly restarted, the pressure might reach a higher level than desired. Methylamphetamine or methoxamine was always kept readily available to combat excessive hypotension should this develop during or after the operation.
Results A rapid fall in mean arterial blood pressure occurred in every case in which Trophenium was administered. In two cases in the general surgical and in four cases in the thoracic series, although the systolic blood pressure fell satisfactorily initially, difficulty was encountered in maintaining a satisfactory steady level, frequent alterations in drip rate being accompanied by swinging of the pressure. In all these cases the drug was being given in a low concentration. Much more stable conditions were obtained when it was given in a strength of 2 mg/ml later in the investigation. In three other cases in the general surgical series the initial fall was not maintained, the blood pressure becoming fixed at an inadequate level of between 80 and 110 mm Hg which was unaffected by changes in drip rate.
Occasionally during the maintenance of hypotension the level of blood pressure became unnecessarily low. On some occasions, in fact, for a short period the sounds were completely inaudible. Sometimes this may have been due to difficulty in hearing the very faint sounds, especially as the pulse pressure frequently narrowed considerably so that the range over which sounds could be heard was limited to only a few beats. Following stoppage of the infusion spontaneous recovery of blood pressure usually occurred. This was sometimes not as rapid as might have been expected from the pharmacological studies, but in every instance the colour remained good and spontaneous respiration, when present, was unaltered. A pressor agent was used in only one of these cases.
Mean systolic blood pressure values at various stages of the operation with standard deviations are shown in table VHI.
Mean values with standard deviations for the duration of operation, anaesthetic and Trophenium administration, recovery time of blood pressure and total dose of the hypotensive agent are shown in table EX.
For the purpose of assessing recovery the arbitrary systolic pressure value of 100 mm Hg was accepted for all cases. Whilst the use of a fixed level such as this is open to objection in view of the individual differences in starting blood pressure level, in general, once the systolic pressure had regained 100 mm Hg the patients were considered fit for return to the ward where they were kept under close nursing supervision with the foot of the bed raised on blocks for 4 to 6 hours. It can be seen that the time taken for the blood pressure to recover when the hypotensive infusion was discontinued differed considerably in the two series and there was a wide variation amongst individual members of each group.
The pulse rate showed no consistent change during controlled hypotension with Trophenium except in the three cases in which the pressure became fixed at an inadequate level. In these cases the pulse rate rose to over 100 beats per 'minute.
The neuromuscular blocking action of d-tubocurarine chloride and gallamine which were used in the usual dosage was not noticeably potentiated by Trophenium in the dosage employed in this investigation.
Postoperative complications.
In the two series in which controlled hypotension was employed one patient died. This was an In four cases in which hypotension was induced with Trophenium there was bleeding from the operation site in the postoperative period.
One was an elderly man who had a transvesical prostatectomy performed. During the operation the mucous membrane of the bladder was found to be thickened and red, with a velvet appearance, bleeding where it was touched. The prostate was enucleated after considerable difficulty in obtaining a reasonable line of cleavage on the right side. Moderate bleeding from the prostatic bed followed but was controlled by diathermy, the blood lost being replaced as it occurred. A Foley catheter was passed per urethram and the bulb blown up sufficiently to counteract oozing from the prostatic bed. The blood pressure returned rapidly to the pre-operative level when the drip containing the hypotensive agent was stopped, and the patient was returned to the ward. Half an hour later, however, he was brought back to the operating theatre because of clot retention, and re-anaesthetized. No hypotensive drug was given on this occasion. There was found to be a general oozing from the trigonal area of the bladder mucosa and a brisk haemorrhage from the prostatic bed. Several attempts were made to stitch the prostatic bed with a Harris boomerang needle, but on each occasion the stitches cut out Haemostasis was obtained by means of a gauze pack in the prostatic bed and layers of oxycel gauze pressed into the posterior lip of the prostatic bed and the surrounding area which was practically denuded of mucosa. A total of 7 pints of blood was given to this patient who made a satisfactory recovery, the pack being removed on the 5th day.
In the thoracic series a recorded drainage into the water seal bottle of 30 fl.oz (750 ml) or more within the first 48 hours after operation was the criterion of significant postoperative haemorrhage. In three cases in the series following segmental resection bleeding occurred requiring further transfusion of blood.
None of the cases showed suppression of urinary secretion after operation. One patient, a man aged 25, developed urinary retention in the immediate postoperative period for which he required catheterization on one occasion. There was no case of paralytic ileus and in fact the only patient who developed bowel symptoms showed signs of hypermotility. As these did not develop until the 4th day after operation and consisted of diarrhoea with blood and mucus which gradually improved on stopping chemotherapy, it seems more likely that they were related to the latter than to any autonomic disturbance produced by Trophenium. There were no cases of thrombophlebitis or of cerebral or coronary thrombosis following operations in which controlled hypotension was used in this series.
Discussion
Control of blood pressure. If arterial hypotension is to be induced as an aid to haemostasis in a carefully selected group of patients undergoing surgical operations in which haemorrhage is likely to cause serious interference with the successful conduct of the operation, the emphasis must be on its controllability. Thus, the longer acting methonium compounds and pendiomide frequently prove unsatisfactory for, if the initial dose is too small, subsequent doses are often ineffective in producing a satisfactory further fall of the blood pressure. On the other hand, when a large initial dose is given, the fall in pressure produced may occasionally be excessive and require the use of a pressor agent to avoid dangerous and prolonged depression of blood pressure. Once the pressure has been raised in this way it is often extremely difficult to modify it by the subsequent injection of a hypotensive drug. Thus a drug with a short duration of action given continuously in the form of a dilute intravenous infusion would appear to offer a greater chance of controllability. Trimetaphan has been found to possess this advantage but to be less satisfactory in certain other respects.
The exact nature of the hypotensive action of trimetaphan is rather ill defined. It is a powerful ganglion blocking agent (Randall et al., 1949) and it also has a direct vasodilator action (McCubbin and Page, 1952) . The intravenous injection of trimetaphan in dogs (Randall et aL, 1949; Mitchell et al., 1951) and in man (Payne, 1956 ) is accompanied by a release of bistamine which might be responsible in part for the hypotension produced by the drug. As far as can be seen from the pharmacological experiments Trophenium owes its hypotensive action to its ganglion blocking properties; it has no direct dilator action and does not release histamine to any significant extent.
Tolerance. Many authors have reported the development of tolerance with ganglion blocking drugs, both when they are given orally in the treatment of systemic hypertension and when given intravenously to induce hypotension during surgery. In the latter instance this may occur within a few minutes, a condition known as tachyphylaxis. It probably occurs less frequently with trimetaphan than with hexamethonium (Voorhoeve, 1955). Voorhoeve (1955) advocated the use of an initial intravenous injection of 100 mg of undiluted trimetaphan to overcome this difficulty and found that following this a stable level of hypotension could be maintained by the continuous infusion of 1 per cent trimetaphan in 5 per cent glucose solution at a rate varying between 1 drop per 4 seconds to 4 drops per second. We have found, however, that in practically every case with trimetaphan this difficulty in achieving a satisfactory fall in blood pressure can be overcome by the use of a high initial drip rate. In the present series with Trophenium, as has been described, we always maintained a fast rate until the blood pressure had fallen to within 10 mm Hg of the desired systolic leveL By this means we obtained a rapid reduction in pressure in every case. Besides being an advantage in probably helping to avoid tachyphylaxis there was also a minimal delay in getting the operation under way. It has been said that there is a danger of acute circulatory failure during the induction of hypotension (Scurr, 1955) and no doubt the more rapid the fall the more likely this would be. However, provided the blood pressure is kept under constant observation throughout this period, although wide differences in susceptibility occur, these are noticed immediately and the appropriate slowing of the drip quickly brings the fall under control.
The type of resistance just described during the induction of hypotension by the intravenous route must be distinguished from the inherent resistance to the maintenance of hypotension in certain individuals, particularly in the young and robust group (Enderby and Pelmore, 1951) . To achieve satisfactory and stable hypotension in this type of patient various other agents have been used to supplement trimetaphan. Thus, Anderson and McKissock (1953) used procaine amide in the manner described by Mason and Pelmore (1953) to compensate for inadequate results obtained with hexamethonium. Scurr and Wyman (1954) added pentamethonium and Loew (1954) used pendiomide. In addition to the use of a second hypotensive agent, various other measures have been advocated to assist in lowering the blood pressure in resistant subjects. Thus, the application of negative pressure to the legs has been used by Saunders and his associates (Saunders, 1952; James, Coulter and Saunders, 1953) to reduce the effective circulating blood volume by trapping blood in the veins of the lower extremities. This is a modification of the usual method of producing venous pooling by posture. It is a valuable aid wherever possible to position the patient with the operation site in a nondependent position and in our cases this is done after the patient is anaesthetized and before hypotension is induced. We are, however, strongly of the opinion that it is unjustifiable in any circumstances to use a head up position and all patients in the present investigation were in a strictly horizontal or slightly head down position. Deepening the level of anaesthesia can also be employed to aid in the reduction of blood pressure, but in general we believe that this is unwise unless anaesthesia has become unnecessarily light.
If a satisfactory level is not obtained before the operation is started or if the blood pressure is allowed to "escape" after a satisfactory initial fall, large quantities of trimetaphan may be given with rather inadequate results. It is therefore very important to achieve the desired level of hypotension before the initial skin incision is made. As well as an undesirable rise in blood pressure which may subsequently be difficult to get under control, this mistake may introduce another factor of considerable importance, namely excessive bleeding in the early stages of the operation. If this occurs at a time when the autonomic ganglia are incompletely blocked a compensatory vasoconstrictor mechanism may be called into play which may be difficult to overcome. Further, the loss of blood will undermine the confidence of the operator in the procedure. It also adds another complicating factor which is highly undesirable, namely lowering the circulating blood volume, a state which is poorly tolerated at low pressures.
Adrenaline sensitization. In three of our cases we were unable by the use of Trophenium alone to maintain a satisfactory level of hypotension. Thus, the systolic pressure showed an initial rapid fall to between 70 and 80 mm Hg and although slowing of the drip rate was not excessive the pressure began to rise and despite repeated speeding up of the drip the systolic pressure rose to the region of 80-110 mm Hg. Thereafter throughout the period of administration of Trophenium the blood pressure was uninfluenced by wide variations in drip rate and even by the administration of 50-100 mg of the undiluted drug intravenously. Zaimis (1955 Zaimis ( , 1956 ) has shown that this diminished effect on blood pressure following subsequent doses of ganglion blocking drugs is due not to a lowered sensitivity of the ganglionic synapse but to a sensitization of the effector cells to adrenaline and noradrenaline, an effect more apparent under such a condition as surgical anaesthesia. She points out that this decreasing response from the blood pressure could be shown clinically to be due to a peripheral action of adrenaline by the administration of an antiadrenaline substance but for the practical difficulty that none of those at present available is a powerful antagonist of the intrinsically liberated sympathomimeric amines. In addition, an antiadrenaline substance used for this purpose would need to have a short duration of action. It is interesting that, in these three patients, as with similar cases receiving trimetaphan where the blood pressure became fixed, the pulse rate increased and there was marked pallor of the face and wide dilatation of the pupils indicating an increase in peripheral sympathetic tone. While the pupils are occasionally large during the administration of hypotensive agents, the size varied considerably, most, however, showing some degree of dilatation.
This development of tachyphylaxis due to sensitization of the peripheral receptors to adrenaline and noradrenaline may be enhanced by the gradual reduction of the blood pressure with ganglion blocking drugs. Under these conditions reflex pressor activity would increase the amounts of adrenaline and noradrenaline being liberated, as would operative stimuli and haemorrhage occurring before ganglion blockade had lowered the blood pressure to hypotensive levels.
Swinging blood pressure level. It has been noted that in a few patients difficulty was met in maintaining a steady level of systolic blood pressure with Trophenium as has been described with trimetaphan (Little, 1954) . This is, no doubt, due largely to the fact that some patients are more susceptible to these drugs than others and develop little or no tolerance during their administration. Another factor of importance when a drug with a very short duration of action is being given is accurate control of the rate of administration. Thus, while in most cases the drip was easily regulated by the ordinary screw clip, occasionally extraneous factors such as compression or movement of the arm by one of the surgical team could cause an alteration in the drip rate. In eight cases a polythene catheter was inserted into an arm vein and the hypotensive agent given at an accurately controlled rate from a motor driven syringe. This method was, however, unnecessarily cumbersome and little trouble was experienced with the drip if the needle was inserted into the cephalic vein on the radial side of the wrist and the arm carefully positioned before the hypotension was induced. The concentration of Trophenium in saline was also of importance in determining the stability or otherwise of the blood pressure during the period of controlled hypotension. It was found that with the use of dilute solutions, less than 2 mg/ml, swinging of the pressure was more likely Time of recovery of blood pressure. The duration of action of the hypotensive drug is a primary factor in determining tie time taken for the blood pressure to return to normal after the administration has been stopped. There are, however, many other factors; thus, recovery time will be affected by the level of hypotension maintained (table  VIII) , its duration and the total quantity of drug used (table IX) . Individual variations in patients such as age (table V) , general condition (table VI) and pre-operative level of blood pressure (table  VIII) , surgical factors including the nature of the operation, its duration, blood loss, position of the patient and body temperature (Zaimis, 1955) , and anaesthetic factors such as agent, duration (table IX) , depth of anaesthesia, may all influence in some degree the length of time before restoration of the blood pressure to normal level. Finally, in the postoperative period, recovery from hypotension may be affected by administration of drugs such as atropine and neostigmine, the return of spontaneous breathing, the replacement of blood, tilting of the table, and changes in position of the patient. From table IX it would appear that the recovery time in the two series is closely related to the duration of the operation, anaesthetic and infusion, but not to the total dose of hypotensive agent used which is remarkably similar in the two series.
Complications. A review of 381 thoracotomies carried out on 363 patients for pulmonary tuberculosis has been made with the object of relating the incidence of postoperative haemorrhage to the use of hypotensive agents (Tough, 1956) . In 268 of these, various hypotensive agents have been employed including hexamethonium, trimetaphan, Trophenium, and in the others similar operations were carried out under the same type of general anaesthesia but without the use of a hypotensive drug. The incidence of haemorrhage in the whole series was 10.2 per cent, that in the group in which hypotension was used being 10.4 per cent and in the group without hypotension 9.7 per cent. It was concluded that in this series the use of a hypotensive agent in conjunction with anaesthesia had no significant effect on the incidence of postoperative haemorrhage.
Due to their action in blocking parasympathetic visceral ganglia, all drugs which block autonomic ganglion transmission depress motor activity of the gastro-intestinal tract and urinary bladder. This action has been utilized in the employment of hexamethonium in the treatment of peptic ulcer (Kay and Smith, 1950) . Constipation, paralytic ileus and urinary retention, therefore, constitute possible complications following the use of ganglion blocking drugs. The occurrence of these in the published clinical reports are, however, rare and where meteorism was observed to occur, it was thought likely that it was due to other causes (Holmes, 1956) , as Douthwaite and Thorne (1951) found that the maximal duration of action of hexamethonium on the gut was 6 hours. In view of the fact that Trophenium is chemically related to atropine, which also possesses thes; effects on intestinal and urinary motor function, it might be expected that complications involving atony of these organs were likely to be enhanced by this agent. However, as has been already described in the pharmacological report, the atropine-like side actions of Trophenium are negligible. It might therefore be expected that complications of this nature would be no more frequent with Trophenium than with other ganglion blocking agents.
In two cases in the thoracic series, patients suffering from diabetes mellitus were given Trophenium to induce hypotension. Griffiths (1953) has shown that there is a tendency for the blood sugar to fall following the administration of hexamethonium. The hypoglycaemia may become very profound without being apparent since the usual symptoms of the condition, namely sweating, palpitations, restlessness and anxiety, are due to sympathetic and adrenal discharge and are prevented by ganglionic blockade. In our cases a continuous infusion of 5 per cent glucose solution was given throughout the period of Trophenium administration. Tachycardia did not occur. There was no unusual effect on the diabetic condition observed during the postoperative period.
SUMMARY AND CONCLUSIONS
Preliminary trials with a new ganglion blocking agent, Trophenium, to produce controlled hypo-tension during general anaesthesia and surgery are described.
The drug has been employed on 76 occasions during general surgical and thoracic operations where it was considered that a reduction in bleeding would be of benefit to the patient.
Trophenium has been found to be an effective hypotensive agent when administered by intravenous drip infusion, a satisfactory stable level of blood pressure being obtained in the majority of cases. In six cases, however, difficulty was experienced in maintaining a steady level of hypotension, frequent alterations in drip rate being accompanied by swinging of the pressure.
All patients in the present investigation were in a horizontal or slightly head down position. Posture depended almost entirely on the nature and site of the surgical procedure and only to a minor degree was it utilized as an aid in producing hypotension. Despite this, in all but three cases an adequate hypotensive level was achieved.
There was one death in the series. This occurred 26 days after operation and appeared to be unrelated to the induced hypotension. The non-fatal postoperative complications are tabulated and discussed.
From this trial we believe that Trophenium is a satisfactory drug for the production of controlled hypotension during surgery. As its hypotensive action is of short duration and appears to be due to a specific ganglion blocking effect it is readily controllable by alterations in the drip rate. We consider that it merits an extended clinical trial.
